The Future of AI in Biotechnology: Collaborative Innovations and Challenges

Drausin Wulsin, Director of ML at Immunai, joins Daniel & Chris to talk about the role of AI in immunotherapy, and why it is proving to be the foremost approach in fighting cancer, autoimmune disease, and infectious diseases.

The large amount of high dimensional biological data that is available today, combined with advanced machine learning techniques, creates unique opportunities to push the boundaries of what is possible in biology.

To that end, Immunai has built the largest immune database called AMICA that contains tens of millions of cells. The company uses cutting-edge transfer learning techniques to transfer knowledge across different cell types, studies, and even species.

Join the discussion

Changelog++ members support our work, get closer to the metal, and make the ads disappear. Join today!

Featuring:

• Drausin Wulsin – LinkedIn
• Chris Benson – Website, GitHub, LinkedIn, X
• Daniel Whitenack – Website, GitHub, X

Show Notes:

• Immunai
• Immunai Fact Sheet
• Drausin Wulsin | LinkedIn
• Drausin Wulsin | Google Scholar

Something missing or broken? PRs welcome!